Bumsuk Hahm, PhD, and his colleagues at MU have received a $1.8 million grant from the National Institutes of Health to examine how the enzymes influence the immune system’s ability to fight infection. Called sphingosine 1-phosphate lyase (SPL) and sphingosine kinase 1 (SK1), they are among a group of metabolizing enzymes that affect many cellular processes, including cell growth, survival, movement and specialization.
“We know these enzymes influence multiple biological mechanisms and could lead to promising drug candidates, but scientists have never studied how these enzymes could be used to fight influenza,” said Hahm, an assistant professor of surgery, molecular microbiology and immunology. “There are a lot of seasonal flu strains that are resistant to current treatments, including some strains that could cause a global pandemic, so it’s important that we identify and develop new targets for the treatment of influenza.”
In a study published in the Journal of Virology, Hahm’s research revealed that the enzymes affect the immune system’s ability to detect viruses and resist infection. The new NIH grant will allow him to translate his study from cells to mice, an important step toward the development of a new treatment for humans.
“We found that when we alter the enzymes, the SPL enzyme stops the flu virus’ ability to replicate, while the SK1 enzyme helps the virus to replicate,” Hahm said. “If we can specifically activate SPL or inhibit SK1, we can identify a target for drug therapies that will block the spread of the influenza virus.”
In November 2011, the MU School of Medicine presented Hahm with its most prestigious award for scientists, the Dorsett L. Spurgeon Distinguished Medical Research Award. Hahm received his doctorate in molecular virology from Pohang University of Science and Technology in South Korea and then joined the virology division at the Scripps Research Institute in La Jolla, Calif. At Scripps, Dr. Hahm studied viral immunology and viral pathogenesis before joining the MU School of Medicine as a faculty member in 2008.
Laura Gerding | Newswise Science News
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy